Renaissance Technologies (RenTech)'s CLOV Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 3.4 M shares of Clover Health Investments, Corp. (CLOV) worth $5.99 M, representing 0.01% of the portfolio. First purchased in 2022-Q1, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in CLOV, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2023, adding 2.45 M shares. Largest reduction occurred in Q4 2025, reducing 3.22 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Clover Health Investments (CLOV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Clover Health Investments (CLOV) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -1.09 M | Reduce 24.26% | 3.4 M | $1.76 |
| Q4 2025 | -3.22 M | Reduce 41.77% | 4.49 M | $2.35 |
| Q3 2025 | -2.78 M | Reduce 26.50% | 7.71 M | $3.06 |
| Q2 2025 | -530,800 | Reduce 4.81% | 10.49 M | $2.79 |
| Q1 2025 | -42,200 | Reduce 0.38% | 11.02 M | $3.59 |
| Q4 2024 | -1.41 M | Reduce 11.32% | 11.07 M | $3.15 |
| Q3 2024 | +1.21 M | Add 10.71% | 12.48 M | $2.82 |
| Q2 2024 | -124,300 | Reduce 1.09% | 11.27 M | $1.23 |
| Q1 2024 | -1.19 M | Reduce 9.46% | 11.4 M | $0.79 |
| Q4 2023 | +2.18 M | Add 20.94% | 12.59 M | $0.95 |
| Q3 2023 | +1.56 M | Add 17.63% | 10.41 M | $1.08 |
| Q2 2023 | +2 M | Add 29.19% | 8.85 M | $0.00 |
| Q1 2023 | +2.45 M | Add 55.56% | 6.85 M | $0.00 |
| Q4 2022 | +421,700 | Add 10.59% | 4.4 M | $0.00 |
| Q3 2022 | +2.35 M | Add 144.28% | 3.98 M | $1.70 |
| Q2 2022 | +674,740 | Add 70.67% | 1.63 M | $2.14 |
| Q1 2022 | +954,800 | New Buy | 954,800 | $3.55 |
Renaissance Technologies (RenTech)'s Clover Health Investments Investment FAQs
Renaissance Technologies (RenTech) first purchased Clover Health Investments, Corp. (CLOV) in Q1 2022, acquiring 954,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Clover Health Investments, Corp. (CLOV) for 17 quarters since Q1 2022.
Renaissance Technologies (RenTech)'s largest addition to Clover Health Investments, Corp. (CLOV) was in Q1 2023, adding 6,848,400 shares worth $5,788.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 3,401,541 shares of Clover Health Investments, Corp. (CLOV), valued at approximately $5.99 M.
As of the Q1 2026 filing, Clover Health Investments, Corp. (CLOV) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Clover Health Investments, Corp. (CLOV) was 12,586,700 shares, as reported at the end of Q4 2023.